Hyperfine (NASDAQ:HYPR – Get Free Report) had its price target hoisted by Wells Fargo & Company from $1.10 to $1.29 in a research note issued on Tuesday,Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price objective suggests a potential upside of 51.66% from the stock’s current price.
Hyperfine Stock Down 6.8 %
Hyperfine stock opened at $0.85 on Tuesday. Hyperfine has a 12-month low of $0.76 and a 12-month high of $1.90. The business’s 50-day moving average price is $1.07 and its two-hundred day moving average price is $1.01. The stock has a market cap of $62.05 million, a PE ratio of -1.49 and a beta of 0.94.
Hyperfine (NASDAQ:HYPR – Get Free Report) last released its earnings results on Monday, March 17th. The company reported ($0.14) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.02. Hyperfine had a negative return on equity of 57.54% and a negative net margin of 309.42%. The firm had revenue of $2.32 million for the quarter, compared to analysts’ expectations of $2.30 million. During the same quarter in the previous year, the business posted ($0.15) earnings per share. As a group, analysts expect that Hyperfine will post -0.57 earnings per share for the current year.
Institutional Inflows and Outflows
About Hyperfine
Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.
Featured Articles
- Five stocks we like better than Hyperfine
- Best Stocks Under $5.00
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Alphabet’s Officially In A Bear Market—Time To Buy?
- 3 Stocks to Consider Buying in October
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for Hyperfine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperfine and related companies with MarketBeat.com's FREE daily email newsletter.